We are live on ! Find out more
SC

Searle & Co Portfolio holdings

AUM $445M
1-Year Est. Return 41.72%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+41.72%
3 Year Est. Return
+93.84%
5 Year Est. Return
+130.57%
10 Year Est. Return
+365.42%
AUM
$104M
AUM Growth
+$6.94M
Cap. Flow
+$2.78M
Cap. Flow %
2.67%
Top 10 Hldgs %
32.54%
Holding
115
New
11
Increased
40
Reduced
21
Closed
4

Top Buys

Rank Stock Value
1
YUM icon
Yum! Brands
YUM
+$542K
2
XIFR
XPLR Infrastructure LP
XIFR
+$536K
3
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$417K
4
RH icon
RH
RH
+$395K
5
QQQ icon
Invesco QQQ Trust
QQQ
+$317K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.08M
2
GE icon
GE Aerospace
GE
+$745K
3
GSK icon
GSK
GSK
+$697K
4
XOM icon
ExxonMobil
XOM
+$430K
5
JNJ icon
Johnson & Johnson
JNJ
+$352K

Sector Composition

Rank Sector Weight
1 Healthcare 25.86%
2 Energy 14.81%
3 Financials 10.04%
4 Industrials 9.49%
5 Technology 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APC
51
DELISTED
Anadarko Petroleum
APC
$619K 0.59%
12,595
+1,875
+17% +$115K
CVX icon
52
Chevron
CVX
$392B
$617K 0.59%
6,940
+50
+0.7% +$4.51K
HD icon
53
Home Depot
HD
$331B
$586K 0.56%
4,473
– –
MCK icon
54
McKesson
MCK
$100B
$584K 0.56%
3,000
+1,000
+50% +$189K
BGS icon
55
B&G Foods
BGS
$287M
$560K 0.54%
16,500
– –
MDLZ icon
56
Mondelez International
MDLZ
$79.5B
$539K 0.52%
12,301
-591
-5% -$26.4K
PSX icon
57
Phillips 66
PSX
$84.9B
$539K 0.52%
6,732
+2,182
+48% +$188K
EMN icon
58
Eastman Chemical
EMN
$8B
$533K 0.51%
8,000
– –
VZ icon
59
Verizon
VZ
$195B
$505K 0.48%
11,008
-854
-7% -$38.8K
PTX
60
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$500K 0.48%
17,250
– –
ETN icon
61
Eaton
ETN
$161B
$496K 0.48%
9,500
+100
+1% +$5.42K
MMM icon
62
3M
MMM
$90.9B
$474K 0.45%
3,861
+1,828
+90% +$235K
BHI
63
DELISTED
Baker Hughes
BHI
$473K 0.45%
10,000
– –
EPD icon
64
Enterprise Products Partners
EPD
$82.3B
$462K 0.44%
17,490
– –
BN icon
65
Brookfield
BN
$104B
$455K 0.44%
42,714
– –
DEO icon
66
Diageo
DEO
$49B
$442K 0.42%
4,100
– –
CB
67
DELISTED
CHUBB CORPORATION
CB
$438K 0.42%
3,350
– –
ABT icon
68
Abbott
ABT
$183B
$437K 0.42%
10,169
+1,669
+20% +$73.7K
QCOM icon
69
Qualcomm
QCOM
$155B
$428K 0.41%
8,532
+532
+7% +$28.4K
LBY
70
DELISTED
Libbey, Inc.
LBY
$418K 0.4%
20,000
– –
GLW icon
71
Corning
GLW
$119B
$412K 0.4%
23,000
– –
JPM icon
72
JPMorgan Chase
JPM
$935B
$407K 0.39%
6,399
-569
-8% -$37.1K
NEE icon
73
NextEra Energy
NEE
$181B
$404K 0.39%
15,600
+4,000
+34% +$101K
CSCO icon
74
Cisco
CSCO
$457B
$390K 0.37%
14,782
+82
+0.6% +$2.26K
EOG icon
75
EOG Resources
EOG
$79.2B
$390K 0.37%
5,600
– –
1 2
3
4 5

Similar funds

RWM
Rialto Wealth Management Syracuse, New York $445M AUM 15.58% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return
WC
Weil Company San Diego, California $445M AUM 14.95% 1-Year Est. Return
MLIC
Mandatum Life Insurance Company Helsinki, Finland $445M AUM 26.43% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $444M AUM 44.44% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
WCP
Welch Capital Partners Harrison, New York $444M AUM 21.45% 1-Year Est. Return
ACA
Aspire Capital Advisors Seattle, Washington $444M AUM 16.47% 1-Year Est. Return

Searle & Co's Q4 2015 Portfolio in Review

As of Q4 2015, Searle & Co held 115 positions worth $104M, up 7.1% from $97.3M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Searle & Co's Q4 2015 filing shows 11 new, 40 increased, 21 reduced and 4 closed positions. Its largest new stake was RH: 4,250 shares worth $332K. The largest sale was Pfizer, an estimated $1.08M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Energy and Financials.

  • Searle & Co's largest Q4 2015 buy was RH: 4,250 shares worth $332K.
  • Searle & Co added most to Yum! Brands in Q4 2015, an estimated $542K increase.
  • Searle & Co's biggest Q4 2015 reduction was Pfizer, cutting an estimated $1.08M.
  • Searle & Co fully exited GSK in Q4 2015, selling an estimated $697K.
  • Searle & Co's ten largest holdings make up 33% of its $104M portfolio in Q4 2015.
  • Searle & Co opened 11 new positions and closed 4 in Q4 2015.
  • Searle & Co's portfolio value rose 7.1% quarter-over-quarter to $104M.

Based on Searle & Co's 13F filing for Q4 2015, filed 11 Jan 2016.